biological therapies for schizophrenia Flashcards
1
Q
Drug therapy
A
- most commonly used treatment
- called anti-psychotic drugs
- these can be taken as tablets, syrups or injections
- can be required to be taken for short or long-term use
2
Q
Typical Anti-psychotics
A
1st type of antipsychotic that has been around since the 50s
3
Q
Typical Anti-psychotics: Chlorpromazine
A
- it can be taken as a tablet, syrup or injection
- when taken orally it can go up to 1000mg
- does have declined over the years
- it blocks dopamine receptors reducing the amount of dopamine
- can reduce symptoms like hallucincations
- can also be a sedative as it affects the histamine receptors
- it can be used to calm patients down
4
Q
Atypical Anti-psychotics: Clozapine
A
- developed in the 60s to reduce the side effects of typical drugs and psychotic symptoms
- it was found to be more effective in relieving symptoms of schizophrenia
- used today but patients are checked against agranulocytosis
not available as an injection - a daily dose is lower to 300-450mg per day
- binds to dopamine receptors and also serotonin & glutamate receptors
- meant to improve mood & reduce depression, anxiety and improve cognitive functioning
- sometimes prescribed to those at risk of suicide
5
Q
Atypical Anti-psychotics: Risperidone
A
- developed in the 90s
- created to reduce effects but without as many side effects as Clozapine
- it can taken as a tablet, syrup or injection
- small doses given at the start to build up to a daily dose of 4-8mg
- binds to dopamine and serotonin receptors more strongly
- evidence to suggest that the smaller dose causes less side effect
6
Q
AO3: Evidence for effectiveness (S)
A
-
Thornley et al (2003): reviewed studies comparing effects of Chlorpromazine to control conditions where patients received a placebo
- results from 13 trials with 1121 ppts showed that Chlorpromazine was associated with better overall functioning & reduced symptom severity
- data from 3 trials with 512 ppts showed that relapse rate was lower in the Chlorpromazine was taken
-
Meltzer (2012): concluded that Clozapine is more effective than typical antipsychotics & other atypical antipsychotics
- it is effective in 30-50% of treatment-resistant cases where typical antipsychotics failed
- other studies have compared the effectiveness if Clozapine & other atypical drugs like Risperidone
- results have been inconclusive maybe as some respond better to one drug or the other
- evidence suggests that drugs are effective in reducing symptoms
7
Q
AO3: Serious side effects (W)
A
- typical antipsychotics are associated with side effects including dizziness, agitation, sleepiness, stiff jaw , weight gain & itchy skin
- long term use can lead to tardive dyskinesia
- involuntary facial movements such as grimacing, blinking & lip smacking
- caused by dopamine supersensitivity
- most serious side effect is neuroleptic malignant syndrome (NMS)
- results in high temperature, delirium, coma and can be fatal
- believed to be caused by the drug blocking dopamine action in the hypothalamus (area that regulates body systems)
- typical doses have decline and NMS has become rarer (0.1% to over 2%)
- atypical antipsychotics were designed to overcome the side effects of typical antipsychotics
- side effects still exist & patients taking Clozapine have to be regularly tested for agranulocytosis
8
Q
AO3: chemical cosh arguement (W)
A
- widely believed that antipsychotics are used for the benefit of the medical staff rather than the patients
- the drugs make patients easier to work with
- it is for short-term use to calm patients is what is recommended and that this practice is seem as human rights abuse by some
9
Q
AO3: Use of antipsychotics depends on the dopamine hypothesis (W)
A
- original hypothesis suggests that high levels of dopamine activity in the sub-cortex of the brain (hyperdopaminergic)
- later hypothesis suggests that there are low levels of dopamine in other areas (hyperdopaminergic)
- not clear how antipsychotics work as they are dopamine antagonists
- some believe that antipsychotics don’t work
10
Q
AO3: problems with evidence for effectiveness (W)
A
-
Healy (2012) suggested that some successful trials have had their evidence published multiple times exaggerating evidence for positive effects
- since they have calming effects and it is easy to show positive effects which is not the same as saying they reduce the severity of psychotic symptoms
- also states that studies assess short term benefits than long-term benefits and compare patients who keep taking antipsychotics with those suffering withdrawal having stopped taking them